MétaCan
Menu
Back to cohort

Abstract SS02-04: How much can we afford to pay for new drugs, and how do we make those decisions?

2010· article· en· W2766865378 on OpenAlexaboutno aff
Thomas J. Smith

Bibliographic record

VenueCancer Research · 2010
Typearticle
Languageen
FieldEconomics, Econometrics and Finance
TopicEconomic and Financial Impacts of Cancer
Canadian institutionsnot available
Fundersnot available
KeywordsNiceExcellenceMedicineCancer drugsCitationCancerCompetitor analysisActuarial scienceFamily medicineMarketingBusinessPolitical scienceInternal medicineLaw

Abstract

fetched live from OpenAlex

Abstract Cancer and overall medical care costs are rising at an unsustainable rate. At the same time there are a plethora of new cancer drugs with some activity, all coming to market with a cost of $3000-10,000/month, independent of their absolute benefit. And the cost of drugs does not fall when there are competitors. How should patients, payers, physicians and society choose, in the real world of limited resources? We will explore several alternatives including US and Canadian models and the UK NICE (National Institute for Health and Clinical Excellence) model. Citation Format: Thomas J. Smith. How much can we afford to pay for new drugs, and how do we make those decisions? [abstract]. In: Proceedings of the AACR 101st Annual Meeting 2010; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr SS02-04

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.006
metaresearch head score (Gemma)0.037
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Theoretical or conceptual · Consensus signal: none
GenreCandidate signal: Commentary · Consensus signal: Commentary
Teacher disagreement score0.061
Threshold uncertainty score0.204

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0060.037
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0010.002
Science and technology studies0.0010.001
Scholarly communication0.0060.004
Open science0.0010.001
Research integrity0.0030.003
Insufficient payload (model declined to judge)0.0610.008

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.136
GPT teacher head0.370
Teacher spread0.234 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designTheoretical or conceptual
Domainnot available
GenreCommentary

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2010
Admission routes1
Has abstractyes

Explore more

Same venueCancer ResearchSame topicEconomic and Financial Impacts of CancerFrench-language works237,207